ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
304
|
71K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
14 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
28K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
5 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
28K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
15 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
179
|
28K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
11 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
28K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
9 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
28K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
14 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
28K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
illdrink2that
|
197 |
48K |
23 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
48K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
28K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
18 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
28K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
11 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
179
|
28K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
14 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
179
|
28K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
11 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
179
|
28K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
19 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
179
|
28K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
304
|
71K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
share dumping
|
|
illdrink2that
|
17 |
3.7K |
11 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
17
|
3.7K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
illdrink2that
|
126 |
28K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
126
|
28K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
illdrink2that
|
179 |
28K |
4 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
179
|
28K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
22 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
304
|
71K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
24 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
971
|
226K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
21 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
971
|
226K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
5 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
971
|
226K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
illdrink2that
|
77 |
17K |
21 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
77
|
17K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
illdrink2that
|
77 |
17K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
77
|
17K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
13 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
971
|
226K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
11 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
971
|
226K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
9 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
304
|
71K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
23 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
971
|
226K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
21 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
304
|
71K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
27 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
304
|
71K
|
27
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
26 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
971
|
226K
|
26
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
illdrink2that
|
11K |
4.1M |
18 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
11K
|
4.1M
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
23 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
304
|
71K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
14 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
11 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
14 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
10 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
971
|
226K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
28 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
971
|
226K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
illdrink2that
|
111 |
33K |
28 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
33K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
illdrink2that
|
209 |
46K |
26 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
46K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
illdrink2that
|
323 |
71K |
15 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
323
|
71K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
illdrink2that
|
304 |
71K |
23 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
304
|
71K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
illdrink2that
|
45 |
12K |
23 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
45
|
12K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
8 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
971
|
226K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
illdrink2that
|
971 |
226K |
26 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
971
|
226K
|
26
|
|
ASX - By Stock
|
FBU |
Re:
Ann: Fletcher Building dismisses BGC claims & provides update
|
|
illdrink2that
|
25 |
10K |
3 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
25
|
10K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
illdrink2that
|
430 |
102K |
11 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
430
|
102K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
illdrink2that
|
111 |
33K |
15 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
111
|
33K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Partners with Berry Consultants for MND Phase 2/3
|
|
illdrink2that
|
98 |
22K |
22 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
98
|
22K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Alzheimer's and Monepantel
|
|
illdrink2that
|
17 |
3.5K |
18 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
17
|
3.5K
|
18
|
|